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AbStrACt
background: Social determinants of health (SDOH) may influence the probability of people living with HIV also being   
infected with hepatitis C virus (HCV). We compared the SDOH of adults co-infected with HCV/HIV with that of HIV mono-
infected adults to identify factors independently associated with HCV infection. 
Methods: In this cross-sectional study, face-to-face interviews were conducted with 509 HIV-infected adults affiliated with 
or receiving services from community-based AIDS service organizations (CBAOs). The primary outcome measure was self-
reported HCV infection status. Chi-square, Student’s t tests, and Wilcoxon rank-sum tests were performed to compare SDOH 
of HCV/HIV co-infected participants with that of HIV mono-infected participants. Multivariable hierarchical logistic regres-
sion was used to identify factors independently associated with HCV co-infection. 
results: Data on 482 (95 HCV/HIV co-infected and 387 HIV mono-infected) adults were analyzed. Compared with partici-
pants infected with HIV only, those who were co-infected with HIV and HCV were more likely to be heterosexual, Aboriginal, 
less educated and unemployed. They were more likely to have a low income, to not be receiving antiretroviral treatment, to 
live outside the Greater Toronto Area (GTA), to use/abuse substances, experience significant depression, and utilize addic-
tion counselling and needle-exchange services. They also were more likely to report a history of homelessness and perceived 
housing-related discrimination and to have moved twice or more in the previous 12 months. Factors independently associ-
ated with HCV/HIV co-infection were history of incarceration (odds ratio [OR] 8.81, 95% CI 4.43–17.54), history of homeless-
ness (OR 3.15, 95% CI 1.59–6.26), living outside of the GTA (OR 3.13, 95% CI 1.59–6.15), and using/abusing substances in the 
past 12 months (OR 2.05, 95% CI 1.07–3.91).
Conclusion: Differences in SDOH exist between HIV/HCV co-infected and HIV mono-infected adults. History of incarceration, 
history of homelessness, substance use, and living outside the GTA were independently associated with HCV/HIV co-infection. 
Interventions that reduce homelessness and incarceration may help prevent HCV infection in people living with HIV.
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H
epatitis  C  virus  (HCv)  Has  beCome   
increasingly  common among people living with 
HIV. Approximately 30% of people with HIV in-
fection worldwide and 20% of Canadians living with HIV 
are also infected with HCV.
1–4 In Canada, HCV is trans-
mitted mainly through the sharing of injection drug use 
equipment and the receipt of blood and blood products.
5–6 
Other mechanisms of transmission include travelling or 
living  in  HCV-endemic  countries,  sharing    equipment 
for inhalation drug use (such as crack pipes), sexual con-
tact, perinatal or mother-to-child transmission, tattoo-
ing or body piercing with contaminated equipment, and 
the sharing of personal hygiene items such as razors and 
toothbrushes; these modes of transmission account for a 
small proportion of HCV cases.
1,2,7,8–12
In more than 75% of people living with HIV infection, 
acute  HCV  infections  develop  into  chronic  infections.
13 
Among those with chronic HCV infection, HIV infection 
significantly impairs the cell-mediated responses to HCV 
antigens,
14 leading to more rapid liver fibrosis.
15,16 People 
with chronic HCV infection are at higher risk of severe liver 
disease,
17 liver decompensation,
18 progression to an AIDS-
defining event,
19 lower health-related quality of life,
20 and 
death.
18,19 B e c a u s e  o f  t h e i r  i n c r e a s e d  b u r d e n  o f  d i s e a s e ,  
co-infected individuals use more health care services than 
HIV mono-infected individuals.
21 Prevention or early treat-
ment of HCV co-infection would, therefore, benefit individ-
ual patients and the health care system as a whole.
Social  determinants  of  health  (SDOH)  may  have  a 
bearing on an individual’s risk of becoming infected with 
HCV. Raphael
22 defines SDOH as the economic and social 
conditions that determine the extent to which a person 
possesses the physical, social, and personal resources to 
identify and achieve health. These determinants include 
Aboriginal status, education, employment and working 
conditions,  food  security,  health  care  services,  hous-
ing, income and its distribution, the existence of a social 
safety net, social exclusion, unemployment and employ-
ment security.
22 Among Canadians living with HIV, for 
example, injection drug use is a strong predictor of HCV 
infection,
23,24 while injection drug use, in turn, is preva-
lent among Aboriginal people, street youth, current and 
former prisoners, and homeless people.
25,26 Incarcera-
tion and homelessness are increasingly being recognized 
as determinants of health among injection drug users 
and those infected with HCV.
27–29 There is also evidence 
linking HCV infection with other determinants of health, 
including age, gender, ethnicity, education, income, and 
unstable housing.
2,7,30–34  
To  prevent  co-infections  and  provide  effective  care 
for people who are already HCV/HIV co-infected, it is 
important to understand the complex interplay between 
demographic and socioeconomic factors, such as incar-
ceration,  substance  use,  HIV,  and  housing,  that  may 
affect the probability of becoming infected with HCV. 
Housing may play a particularly important role as an 
intermediate  structural  factor  that  links  broader  so-
cietal processes with an individual’s immediate social 
and physical environment and in turn influences health 
and  well-being.
35  Within  the  context  of  HIV,  housing 
is powerfully linked with risk factors for exposure and 
transmission, and with the care and health of persons 
living with HIV.
36–38 However, the potential influence of 
housing instability on HCV infection among those living 
with HIV in Ontario and Canada has not been explored. 
As such, our current study was designed to determine 
the unique contribution of housing characteristics, par-
ticularly  housing  instability  factors,  in  the  context  of 
other social determinants of health for people with HCV/
HIV co-infection.
Methods
Participants. Data for this study came from the 1-year 
follow-up of the Positive Spaces, Healthy Places (PSHP) 
study, an observational study involving a cohort of 602 
people living with HIV infection and affiliated with or 
receiving services from community-based AIDS service 
organizations (CBAOs) in Ontario. The purpose of the 
PSHP study was to examine the impact of housing on 
health and health-related quality of life among people 
living with HIV.
To ensure the representativeness of the study sample, 
participants in the PSHP study were recruited using a 
wide range of access points, including shelters for home-
less people; agencies serving women, families, and youth; 
Aboriginal  organizations;  transitional  housing  provid-
ers; and supportive housing agencies. Efforts were made 
to include harder-to-reach populations such as injection 
drug users and street-involved people (individuals who 
live in and out of hostels and homeless shelters). 
recruitment. Posters and flyers with information about 
the PSHP study were distributed to individuals receiving 
services from CBAOs across Ontario. Calls for study par-
ticipants were also posted in CBAO newsletters and in a 
gay and lesbian news magazine. Interested participants 
were asked to call a toll-free telephone number.  
Of the 676 individuals who expressed interest in par-
ticipating, 602 met the eligibility criteria and were en-
rolled in the PSHP study (see Fig. 1); thus the study’s 
targeted recruitment goal of 600 people was met. Par-
ticipants were eligible if they lived in Ontario and were Open Medicine 2011;5(3)e122
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HIV-positive, were aged 18 years or older, and were able 
to provide informed consent. To minimize bias, recruit-
ment was guided by predefined targets that reflected the 
regional, gender, sexual orientation, and ethnic distri-
bution of HIV prevalence in the province. The 602 indi-
viduals enrolled were from various communities across 
Ontario, including Eastern Ontario (Ottawa, Kingston, 
and Peterborough), Northern Ontario (North Bay, Sud-
bury, and Thunder Bay), South and South Western On-
tario (Niagara Falls, St. Catharines, Hamilton, London, 
Guelph, and Windsor) and the Greater Toronto Area (To-
ronto, Mississauga, Brampton, Oakville, Markham, Osh-
awa, Ajax, and Pickering). 
To reflect the study’s strong commitment to commun-
ity-based research (CBR)
39 and the Greater Involvement 
of People living with HIV and AIDS (GIPA) principle,
40 
all consent forms and questionnaires were administered 
by 7 peer research assistants (PRAs), that is, people liv-
ing with HIV who received training from the study team 
on interviewing techniques, principles of CBR, ethical 
issues in CBR, and CBR in Aboriginal communities. Eth-
ics approval for the PSHP study was obtained from the 
Research Ethics Board of McMaster University, Hamil-
ton, Ontario.
Data collection.  Face-to-face  interviews  were  con-
ducted at baseline (April 2006 to September 2006) and 
at 1-year follow-up (April 2007 to December 2007) using 
a  quantitative  questionnaire  that  was  piloted  with  33 
participants. It took approximately 75 minutes to com-
plete  the  questionnaire/survey.  Interviews  were  con-
ducted at a local CBAO or in a public place (e.g., coffee 
shop), according to the participant’s preference. Study 
participants  were  allowed  to  self-complete  questions 
that were considered confidential (e.g., the Drug Abuse 
Screening Test). Participants were paid an honorarium 
of $60 for the baseline interview and $40 for the 1-year 
follow-up interview. This study, however, uses data from 
the 1-year follow-up interviews only, as data on HCV in-
fection were not collected at baseline.
Outcome measures. The following outcome measures 
were used.
HCV infection.  The primary outcome in this study is 
self-reported HCV co-infection status. At the 1-year fol-
low-up interview, participants were asked whether they 
had ever been tested for HCV and, if they had a history 
of HCV, whether they still had the infection. Those who 
reported a history of HCV diagnosis and still had the in-
fection were considered to be HCV/HIV co-infected. Par-
ticipants with a history of HCV infection who reported 
being clear of the infection at the time of the interview 
were  excluded  to  minimize  potential  misclassification 
bias. 
Sociodemographic characteristics. Data collected on 
sociodemographic characteristics included age, gender, 
sexual  orientation,  Aboriginal  status,  education,  em-
ployment status, and personal income. We categorized 
gender as male, female or transgender; sexual orientation 
as heterosexual and gay, lesbian, or bisexual; Aboriginal 
status as Aboriginal and non-Aboriginal; education as 
less than high school or high school diploma or above; 
employment  status  as  unemployed  or  employed;  and 
income as ≤ CAD$1200/month or > CAD$1200 CAD/
month. Participants were also asked whether they had 
ever been incarcerated; these responses were dichotom-
ized into “have been incarcerated” or “have never been 
incarcerated.” 
Health status and health care utilization. The study 
gathered information on selected HIV disease markers 
(i.e., highest CD4 count in the past 6 months, year of 
HIV diagnosis, history of diagnosis of AIDS, and receipt 
of antiretroviral therapy) and utilization of health care 
services, including addiction counselling and needle ex-
change program, in the past 12 months.  
We categorized recent CD4 counts as ≥ 500 cells/mm
3 
or < 500 cells/mm
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“yes, have been diagnosed with at least 1 AIDS-defining 
condition” or  “have never been diagnosed with an AIDS 
defining condition”; receipt of antiretroviral therapy as 
“not  receiving  antiretroviral  treatment  currently”  or 
“receiving  antiretroviral  treatment.”  Time  since  HIV 
diagnosis was computed by subtracting the year of HIV 
diagnosis from the year the interview was conducted. 
Utilization  of  health  service  was  defined  as  visiting  a 
service provider at least once in the previous 12 months.   
Health-related quality of life. Health-related quality 
of life was assessed using the MOS-HIV survey.
41 This 
survey has 35 items that are used to compute 2 summary 
scores—Physical  Health  Summary  (PHS)  and  Mental 
Health Summary (MHS)—and 10 subscales scores. This 
instrument has high internal consistency and test-retest 
reliability.
42 All scores were used as continuous variables. 
Depression. Depressive symptoms were assessed using 
the Center for Epidemiological Studies Depression Scale 
(CES-D).
43 The CES-D is a self-report scale consisting of 
20 items that assess the presence of depressive symp-
toms in the general population. The CES-D total score 
ranges from 0 to 60, such that higher scores indicate 
more severe depressive symptoms. This instrument has 
high test-retest reliability.
44 A 16-point cut-off was used 
to categorize participants into 2 groups: significantly de-
pressed (i.e., CES-D ≥ 16), or not significantly depressed 
or not depressed (CES-D < 16). 
Alcohol consumption. A l c o h o l  c o n s u m p t i o n  w a s  a s -
sessed  using  the  Alcohol  Use  Disorders  Identification 
Test  (AUDIT-10).
45 The AUDIT-10 has 10 items and is 
designed to assess and identify hazardous alcohol con-
sumption,  alcohol  dependence  and  alcohol-related 
harm. This instrument has high internal consistency and 
test-retest reliability.
46,47 In this paper, however, we used 
responses to items 1 to 3 of the AUDIT survey to dichot-
omize participants into heavy drinkers (i.e., consumed 6 
or more drinks on 1 occasion at least once a month in the 
previous 12 months) and light drinkers (i.e., consumed 5 
or fewer drinks on 1 occasion in the previous 12 months) 
or non-drinkers (i.e., did not consume any alcohol in the 
previous 12 months).  
Substance use. The presence and degree of substance 
use/abuse was assessed using the Drug Abuse Screening 
Test (DAST-20) instrument.
48 The DAST-20 is designed 
to assess and identify the abuse of psychoactive drugs; 
its  validity  is  reported  elsewhere.
49–50 I n  t h i s  a n a l y -
sis, the first item of this instrument was used to assess 
the presence or absence of substance use in the past 12 
months. 
Housing characteristics. Housing-related data collected 
included city/town of current residence; type of hous-
ing (i.e., house, condominium, apartment, a room in a 
hotel/motel/boarding house, HIV housing facility with 
shared kitchen and bathroom, outdoors [including parks 
and streets], couch surfing, and shelter); length of resi-
dence in current housing; amount of rent; receipt of rent 
assistance; difficulty paying housing cost; and number 
of times moved in the past year. Participants were also 
asked whether they were currently homeless, had ever 
been  homeless,  and  had  ever  experienced  housing- 
related  discrimination.  Responses  for  city  or  town  of 
residence were coded as living in the Greater Toronto 
Area (GTA) (i.e., Toronto, Mississauga, Brampton, Oak-
ville, Markham, Oshawa, Ajax, and Pickering) and out-
side of the GTA (i.e., Ottawa, Kingston, Peterborough, 
North  Bay,  Sudbury,  Thunder  Bay,  Niagara  Falls,  St. 
Catharines, Hamilton, London, Guelph, and Windsor). 
We dichotomized type of housing into “homeless or in-
adequately  housed”  (living  outdoors,  including  parks 
and streets; living in a room in a hotel, motel, or board-
ing house; living in a shelter; and couch surfing) or “not 
homeless or adequately housed” (i.e., living in own resi-
dence or renting an apartment, condominium, or house); 
history of homelessness into “I have been homeless at 
least once” or “I have never been homeless”; housing-re-
lated discrimination into “experienced housing-related 
discrimination at least once in my lifetime” or “never ex-
perienced housing-related discrimination”; and number 
of times moved in the past 12 months into “moved twice 
or more” or “moved once or less.”
Several items from another study
51 were adapted for 
our  survey  to  assess  participants’  level  of  satisfaction 
about various aspects of their dwelling (e.g., layout of 
rooms),  meaningful  dimensions  of  their  housing  (e.g., 
“proud  of  my  home”),  and  their  neighbourhood  (e.g., 
satisfied with neighbourhood as a whole). Participants 
were asked to indicate on a Likert scale their level of 
satisfaction (ranging from 1 [very satisfied] to 5 [very dis-
satisfied]), or their agreement with statements describ-
ing  meaningful  dimensions  of  their  housing  (ranging 
from 1 [strongly agree] to 5 [strongly disagree]). For data 
analysis, items measuring satisfaction with dwelling and 
neighbourhood features were dichotomized into satisfied 
(i.e.,  very  satisfied/satisfied)  or  neutral  or  dissatisfied 
(i.e., neutral/dissatisfied/very dissatisfied). Participants’ 
agreements  with  statements  describing  meaningful 
dimensions  of  their  housing  were  dichotomized  into Open Medicine 2011;5(3)e124
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“strongly  agree/agree”  or  “neutral/disagree/strongly 
disagree.” 
Statistical analysis. Data analyses were conducted in 2 
stages. First, means and standard deviations were calcu-
lated for continuous variables, and frequencies were cal-
culated for categorical variables. Characteristics of HIV/
HCV co-infected and HIV mono-infected groups were 
compared using Student’s t test and Wilcoxon rank-sum 
tests for continuous variables and a chi-square test for 
categorical variables. 
A hierarchical multivariable logistic regression model 
was fitted to examine factors independently associated 
with  HCV  co-infection.  Hierarchical  regression  is  not 
constrained by the assumption of independence obser-
vations, allows the use of multiple levels of information 
(thus  providing  additional  statistical  benefits),  and  is 
suited to public health research involving determinants 
of health.
52,53 Variables that were associated (p < 0.05) 
with HCV co-infection in bivariable analyses and sup-
ported by existing literature were considered candidates 
for  the  regression  model.  We  further  examined  Pear-
son product-moment correlation coefficients among the 
candidate variables and allowed only sexual orientation 
(between gender and sexual orientation) and history of 
homelessness (among history of homelessness and cur-
rent homelessness or living in inadequate housing) to 
enter the final model.  
As we were particularly interested in exploring the as-
sociation between housing and HCV co-infection, selected 
variables were entered into the regression model in a set 
of four blocks, with housing variables entered last. First, 
sociodemographic variables were entered into the model. 
Health status variables were entered in the second step, 
followed  by  incarceration  and  substance  use  variables. 
Finally, housing variables were entered into the model. 
Cases with missing data on covariates were omitted 
from the final regression model. To examine the potential 
bias that may arise because of the exclusion or inclusion 
of participants with a history of HCV diagnosis but who 
were clear of the infection at the time of data collection, 
sensitivity analysis was conducted by running the hier-
archical regression model treating the excluded cases first 
as HCV/HIV co-infected and then as HIV mono-infected. 
All analyses were performed using SPSS 16.0 (SPSS Inc., 
Chicago, IL) and all reported p values are two-tailed.
results
In total, 602 people living with HIV were enrolled in 
the PSHP study and completed the baseline interview 
in  2006.  Of  these,  509  (85%)  completed  the  1-year 
follow-up interview in 2007. Table 1 compares the base-
line characteristics of the 509 participants who complet-
ed the 1-year follow-up with the characteristics of the 93 
participants who were lost to follow-up between baseline 
and 1-year follow-up. Those who were lost to follow-up 
were more likely to be homeless or to live in adequate 
housing, to have moved twice or more in the previous 12 
months, to have a history of homelessness, to have a his-
tory of incarceration, to live in the GTA and to be heavy 
drinkers than those who completed the 1-year follow-up 
interview. They were diagnosed with HIV more recently 
and were less likely to be on antiretroviral treatment. 
They also had significantly poor functioning and well-
being as measured by the mental health summary and 
the  general  health  perceptions,  cognitive  functioning, 
mental health, health distress, and quality of life dimen-
sion scores of the MOS-HIV health survey. 
Of the 509 participants who completed the 1-year fol-
low-up and were considered for this analysis, 122 (24%) 
reported a history of diagnosis of HCV infection. Of the 
122 with a history of HCV infection, 27 individuals indi-
cated that they were free of the infection and were exclud-
ed. The 27 participants excluded from this analysis had 
sociodemographic, housing, drug use, and health char-
acteristics that were similar to those of the 482 who were 
included, except for past history of incarceration (43% vs 
24%, p < 0.05). 
Four hundred and eighty-two (482) individuals were 
eligible for this analysis, including 95 HCV/HIV co-in-
fected  and  387  HIV  mono-infected  participants.  CD4 
count was unknown for 81 individuals, and 29 partici-
pants did not provide age information. Ten (10) partici-
pants refused to provide income information. Table 2 
summarizes the sociodemographic, housing, incarcera-
tion, and substance use characteristics of HCV/HIV co-
infected versus HIV mono-infected participants.
There were 120 (25%) women or men-to-women trans-
gendered participants, and 362 men (75%); the mean age 
was 43 years. Co-infected individuals were more likely to 
be heterosexual (57% vs 31%, p < 0.01), to be Aboriginal 
(20% vs 10%, p < 0.01), to have less than a high school 
education (41% vs 16%, p < 0.01), to be unemployed (87% 
vs 72%, p < 0.01), and to report a monthly income of 
$1200 or less (63% vs 49%, p < 0.05). 
Participants  with  HCV/HIV  co-infection  were  more 
likely than participants with HIV mono-infection to live 
outside of the Greater Toronto Area (76% vs 35%, p < 
0.01), to have a history of homelessness (78% vs 31%, p 
< 0.01), to have experienced housing-related discrimina-
tion (51% vs 32%, p < 0.01),to  have moved twice or more 
in the previous 12 months (14% versus 5%, p < 0.01), and Open Medicine 2011;5(3)e125
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Table 1: Baseline characteristics of Positive Spaces, Healthy Places study participants
Completed 1-year 
follow-up    n = 509
Lost to follow-up 
n = 93
Characteristics Mean or % (SD) or N Mean or % (SD) or N
Sociodemographic characteristics
Age (years)*  43.4 (8.5) 41.8 (9.0)
Female or transgender † 25% 125 25% 23
Heterosexual 36% 182 39 % 36
Aboriginal  12% 61 19% 18
Low education (< high school diploma)  21% 108 27% 25
Unemployed  80% 405 83% 76
Low income (≤ $1200/month) ‡ § 60% 290 62% 52
Housing characteristics
Live outside of the GTA a 41% 209 20% 19
Homeless or live in inadequate housing a ¶ 4% 19 16% 15
History of homelessness (lifetime) a 40% 202 56% 52
History of  housing-related discrimination (lifetime)  34% 171 43% 40
Moved twice or more (past 12 months) b 11% 56 18% 17
Incarceration and substance use 
History of incarceration (lifetime) a 29% 148 44% 41
Heavy drinking (past 12 months) a ** 15% 74 26% 24
Substance use (past 12 months) 47% 237 54% 50
Health status
Time since HIV diagnosis a †† 12.5 (6.4) 9.5 (6.7)
Have been diagnosed with AIDS  50% 254 47% 44
Receiving antiretroviral treatment a 77% 391 59% 55
Signifi  cantly depressed (CES-D ≥16)  47% 237 56% 52
Health-related quality of life (MOS-HIV)
Physical health summary (PHS) 43.0 10.7 42.7 9.4
Mental health summary (MHS) a 45.6 11.4 39.4 12.1
General health perceptions b 46.1 10.0 43.6 10.6
Physical functioning  46.0 10.3 46.6 9.8
Role functioning 41.4 10.4 40.5 9.9
Cognitive functioning a 43.8 11.8 37.7 13.2
Pain 48.0 9.3 48.0 9.7
Energy 44.1 10.4 42.1 10.6
Mental health a 47.6 11.6 43.3 11.5
Health distress a 47.5 11.8 42.3 12.5
Social functioning 43.7 13.0 41.4 13.7
Quality of life a 45.7 12.5 41.1 12.6
 a p < 0.01
 b p < 0.05
 * Data missing for 33 participants.
 † Includes 4 male-to-female transgender participants.
 ‡ Baseline data missing for 35 participants. 
 § Data missing for 10 participants at 1-year follow-up.  
 ¶ Includes the homeless (i.e., living on the street, parks, cars) couch-surfers, or those living in shelters or a self-contained room in a
     motel, hotel or boarding house.  
** Consumed  ≥ 6 drinks on 1 occasion, at least once a month.
†† Data missing for 3 participants.
SD = standard deviation. GTA = Greater Toronto Area. CES-D = Center for Epidemiologic Studies Depression Scale. 
MOS-HIV = Medical Outcome Study HIV Health Survey. Open Medicine 2011;5(3)e126
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to be less satisfied with the location of their home (58% 
vs 70%, p < 0.05). They were more likely to report a his-
tory of incarceration (82% versus 18%, p < 0.01) and sub-
stance use (71% versus 31%, p < 0.01) in the previous 12 
months. 
As  summarized  in  Table  3,  co-infected  individuals 
were less likely to be on antiretroviral treatment (74% 
vs 86%, p < 0.01), but were more likely to report a sig-
nificant level of depressive symptoms (64% vs 43%, p < 
0.01). They also reported significantly (p < 0.05) poorer 
health-related quality of life in both physical and mental 
health summary measures of the MOS-HIV. HCV/HIV 
co-infected participants also reported significantly (p < 
0.05) lower scores in general health perception, physical 
functioning,  role  functioning,  cognitive  functioning, 
pain,  and  energy  dimensions  of  the  MOS-HIV  health 
survey. The utilization of services of a family doctor, HIV 
specialist  and  mental  health  providers  in  the  past  12 
months did not differ statistically between HCV/HIV co-
infected and HIV mono-infected participants. However, 
co-infected  participants  reported  higher  utilization  of 
addictions counselling (28% vs 4%,  p < 0.01) and needle 
exchange (24% vs 3%, p < 0.01) services.  
Results of the final hierarchical logistic regression mod-
el are presented in Table 4. None of the sociodemographic 
variables entered in the first block were significant in the 
final model. Similarly, receipt of antiretroviral treatment 
and depression were not associated independently with 
Table 2:  Sociodemographic, housing, incarceration and substance use characteristics of HCV/HIV co-infected and HIV 
mono-infected participants at 1-year follow-up
Characteristics
HCV/HIV 
co-infected   n = 95
HIV mono-infected
n = 387
Mean or % (SD) or N Mean or % (SD) or N
Sociodemographic characteristics
Age (years)  *    44.4 (7.6) 44.3 (8.8)
Female or transgender † 27% 26 24% 94
Heterosexual a 57% 54 31% 119
Aboriginal a 20% 19 10% 39
Have not completed high school a 41% 39 16% 61
Unemployed a 87% 83 72% 278
Monthly income (≤ $1200/month) b ‡ 63% 59 49% 187
Housing characteristics
Live outside of GTA a 76% 72 35% 135
Homeless or live in inadequate housing a § 6% 6 1% 5
History of homelessness (lifetime) a 78% 74 31% 120
History of housing-related discrimination (lifetime) a 51% 48 32% 125
Moved twice or more (past 12 months) a 14% 13 5% 18
Home is at a good location to live my life b 58% 55 70% 269
Satisfi  ed with residence as a whole 63% 60 61% 236
I am proud of my home 62% 59 70% 271
Satisfi  ed with access to health/social service agencies  57% 54 62% 238
Satisfi  ed with neighbourhood as a whole 61% 58 57% 222
I am proud of my neighbourhood 55% 53 64% 247
I feel like I belong in my neighbourhood 55% 52 53% 203
Incarceration and substance use 
History of incarceration (lifetime) a 82% 78 18% 69
Heavy drinking (past 12 months) ¶ 20% 19 13% 52
Substance use (past 12 months)  a  ** 71% 67 31% 120
   a p < 0.01 
  b p < 0.05
  * Data missing for 29 participants. 
 † Includes 4 male-to-female transgender individuals. 
 ‡ Data missing for 10 individuals. 
 § Includes the homeless (i.e., living on the street, parks, cars) couch-surfers, or those living in shelters or self-contained room in a motel, hotel or boarding house.      
 ¶ Consumed ≥ 6 drinks on one occasion at least once a month. 
** Used substances at least once. 
SD = standard deviation. GTA = Greater Toronto Area.Open Medicine 2011;5(3)e127
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and living outside of GTA remained significant in both 
models. However, the effects of magnitudes were slightly 
lower than the final model presented in Table 4. 
Discussion
Although the prevalence of HCV infection among people 
living with HIV in Ontario is estimated to be 12%,
4 our 
study found a 20% prevalence in a community sample. 
Of all variables associated with HCV infection in bivari-
able analyses, only history of incarceration, history of 
homelessness, substance use, and living outside of the 
GTA were independently associated with self-reported 
HCV infection status in multivariable analysis. 
Our finding of a strong association between history 
of incarceration and HCV co-infection is consistent with 
HCV  co-infection.  Both  variables  entered  in  the  third 
block—history of incarceration (OR = 8.81, 95% CI 4.43–
17.54, p < 0.001) and substance use (OR = 2.05, 95 % CI 
1.07–3.91; p < 0.05)—were independently associated with 
being infected with HCV. Among the 5 housing-related 
variables entered in the last block, history of homeless-
ness (OR = 3.15, 95% CI 1.59–6.26, p < 0.01) and living 
outside of the GTA (OR = 3.13, 95% CI 1.59–6.15, p < 0.01) 
were significant in the final regression model. 
To  examine  the  potential  bias  of  excluding  27  par-
ticipants from the analysis, we repeated the regression 
model  first  by  treating  them  as  HCV/HIV  co-infected 
and then as HIV mono-infected. Results of the regres-
sion models (not presented here) showed that history of 
incarceration, history of homelessness, substance use, 
Table 3:  Health status, health care utilization, and health-related quality of life of HCV/HIV co-infected and 
HIV mono-infected participants at 1-year follow-up
Characteristics
HCV/HIV 
co-infected   n = 95
HIV mono-infected
n = 387
Mean or % (SD) or N Mean or % (SD) or N
Health status
Time since HIV diagnosis (years) 12.4 (6.3) 12.4 (6.4)
Have been diagnosed with AIDS  63% 60 54% 209
Receiving antiretroviral treatment a 74% 70 86% 331
Signifi  cantly depressed (CES-D ≥ 16) a 64% 61 43% 167
Health care utilization (previous 12 months)*
Family doctor  81% 77 88% 338
HIV specialist  88% 84 83% 322
Psychiatrist  20% 19 16% 60
Psychologist or mental health counsellor  15% 14 16% 61
Addiction counsellor a 28% 27 4% 17
Needle exchange program a 24% 23 3% 10
Health-related quality of life (MOS-HIV dimensions)
Physical health summary (PHS) a 39.8 (10.8) 43.8 (10.6)
Mental health summary (MHS) b 43.0 (9.8) 46.1 (11.7)
General health perceptions a 43.0 (8.6) 46.7 (10.1)
Physical functioning b 43.8 (10.6) 46.7 (10.1)
Role functioning b 39.0 (9.9) 41.9 (10.4)
Cognitive functioning a 40.6 (11.1) 44.8 (11.7)
Pain a 45.5 (9.8) 48.7 (9.2)
Energy a 41.0 (9.6) 44.8 (10.6)
Mental health 45.6 (10.4) 47.9 (12.0)
Health distress 46.9 (10.9) 49.2 (11.6)
Social functioning 42.3 (13.3) 43.9 (13.1)
Quality of life 45.0 (12.4) 45.8 (12.4)
   a p < 0.01 
  b p < 0.05
 * Visited provider at least once.
 SD = standard deviation. CES-D = Center for Epidemiologic Studies Depression Scale. MOS-HIV = Medical Outcome Study HIV Health SurveyOpen Medicine 2011;5(3)e128
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in  part  to  the  high  HCV  infection  rates  among  injec-
tion drug users in South West, Central West, East, and 
Northern  Ontario,  as  compared  with  Central  East-
ern Ontario, which includes the GTA.
60 In our sample, 
higher proportions of participants from areas outside of 
the GTA reported a history of incarceration, a history of 
homelessness, and substance use. Therefore, the higher 
prevalence of HCV infection outside of the GTA may be a 
reflection of the higher prevalence of HCV risk factors in 
those areas of the province. We also hypothesize that the 
lack or shortage of health care, housing, employment, 
and social support services outside of the GTA compared 
with in the GTA may be a factor for the high prevalence 
of HIV/HIV co-infection. For example, in our sample, 
participants living outside of the GTA were more likely 
to report the need for more needle exchange services and 
addictions counselling than those who lived in the GTA. 
There are limitations to our study. First, our study 
participants are primarily individuals affiliated with or 
receiving services from CBAOs. Although it is not pos-
sible to establish how representative these participants 
were of people living with HIV in Ontario, comparison of 
our participants with epidemiological data on people liv-
ing with HIV in Ontario in 2006 
61 shows some similar-
ity. For example, 76% of our participants were male (vs 
82%), 60% were gay or bisexual men (vs 68%), 91% were 
between the ages of 15 and 60 years (vs 97%). However, 
we cannot rule out the possibility of other biases, since 
individuals  recruited  from  organizations  serving  stig-
matized populations may be different from those who do 
not receive these services,
62 and a study
63 has found that 
evidence showing high infection rates among the prison 
population.
4,54 Prisons may influence the transmission 
of HCV infection among inmates in several ways. First, 
a high proportion of those incarcerated use illicit drugs, 
including injection drugs.
55 Second, because a high pro-
portion  of  incarcerated  individuals  are  infected  with 
HCV,
55 the prison setting may facilitate HCV transmis-
sion among inmates who engage in injection drug use. 
In addition to injection drug use, other risk factors for 
hepatitis C transmission, such as unsafe body piercings 
and unprotected anal sex with male injection drug users 
are also common in prisons.
56,57 The limited access to or 
lack of harm-reduction interventions in prisons, such as 
needle exchange programs or condoms,
55 increases the 
probability that inmates will contract HCV infection. 
In our sample, history of homelessness was strongly 
associated with HCV co-infection. Previous studies have 
shown a link between homelessness and increased risk 
factors for HIV and HCV infection among injection drug 
users, such as needle sharing, going to a shooting gallery, 
having multiple sexual partners, and having unprotected 
sex.
58,59 Although we did not collect data on current in-
jection drug use, needle sharing, and sexual practices of 
participants, it is possible that those who were homeless 
at some point in their lives were exposed to these HCV 
risk factors. In our sample, 55% of the participants (92% 
of HCV/HIV co-infected and 32% of HIV mono-infected) 
who reported a history of homelessness had also been 
incarcerated in the past.
The  higher  prevalence  of  HIV/HCV  co-infection 
among those living outside of the GTA may be attributable 
Table 4:  HCV co-infection status as a function of sociodemographic, health status, incarceration and substance use/abuse, 
and housing characteristics: odds ratio (95% CI) from hierarchical logistic regression model (N = 482)
Variable Step 1 Step 2 Step 3 Step 4
Heterosexual 2.70 (1.67–4.34)a 2.62 (1.61–4.27)a 2.52 (1.40–4.54)a 1.73 (0.91–3.30)
Aboriginal  1.50 (0.77–2.91)  1.53 (0.78–3.00) 1.06 (0.48–2.35) 0.92 (0.41–2.06)
Education (< High school ) 2.86 (1.69–4.83)a 2.89 (1.69–4.94)a 1.57 (0.82–3.03) 1.58 (0.80–3.12) 
Unemployed  2.15 (1.09–4.21)a 1.78 (0.88–3.60) 1.22 (0.56–2.68) 1.28 (0.56–2.94)
Not on antiretroviral treatment  2.26 (1.25–4.09)a 1.73 (0.86–3.51) 1.78 (0.84–3.76)
Signifi  cant depression (CSE-D ≥ 16)  2.11 (1.27–3.52)a 1.91 (1.04–3.51)b 1.61 (0.83–3.13)
History of incarceration 12.80 (6.75–24.28)a 8.81 (4.43–17.54)a 
Substance use  2.46 (1.33–4.53)a 2.05 (1.07–3.91)b
Live outside of GTA  3.13 (1.59–6.15)a
History of homelessness  3.15 (1.59–6.26)a 
History of housing-related discrimination 0.76 (0.39–1.46)
Moved twice or more (past 12 months)  0.45 (0.16–1.32)
Home is not at a good location  0.97 (0.51–1.85)
a p < 0.01 (two-tailed) 
b p < 0.05 (two-tailed)
CI = confi  dence interval. GTA = Greater Toronto Area. CES-D = Center for Epidemiologic Studies Depression Scale  Open Medicine 2011;5(3)e129
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